|
2019 Conference Publication Patterns of response for combination of PV-10 oncolytic immunotherapy and checkpoint inhibitionAgarwala, Sanjiv S., Ross, Merrick I., Zager, Jonathan, Shirai, Keisuki, Essner, Richard, Smithers, Bernard M., Atkinson, Victoria, Sarson, David and Wachter, Eric A. (2019). Patterns of response for combination of PV-10 oncolytic immunotherapy and checkpoint inhibition. LONDON: BMC. |
|
2019 Journal Article Patients with in-transit melanoma metastases have comparable survival outcomes following isolated limb infusion or intralesional PV-10-A propensity score matched, single center studyRead, Tavis, Fayers, Warren, Thomas, Janine, Wagels, Michael, Barbour, Andrew and Smithers, B. Mark (2019). Patients with in-transit melanoma metastases have comparable survival outcomes following isolated limb infusion or intralesional PV-10-A propensity score matched, single center study. Journal of Surgical Oncology, 119 (6), 717-727. doi: 10.1002/jso.25373 |
|
2019 Book Chapter Treatment of early oesophageal cancerSmithers, B. Mark and Thomson, Iain (2019). Treatment of early oesophageal cancer. Oesophagogastric Surgery - A Companion to Specialist Surgical Practice. (pp. 89-99) edited by S. Michael Griffin. Edinburgh, Scotland: Elsevier. |
|
2019 Conference Publication Melanoma patient survival: Prognostic value of pSTAT5 as a biomarkerChong, S., Rowe, C., Malt, M., Brown, S., Smithers, M. and Khosrotehrani, K. (2019). Melanoma patient survival: Prognostic value of pSTAT5 as a biomarker. Australasian College of Dermatologists, 52nd Annual Scientific Meeting, Melbourne, VIC Australia, 18–21 May 2019. Richmond, VIC Australia: Wiley-Blackwell. |
|
2019 Conference Publication Phase 1b study of PV-10 and anti-PD-1 in advanced cutaneous melanomaAgarwala, Sanjiv S., Ross, Merrick I., Zager, Jonathan S., Shirai, Keisuke, Essner, Richard, Smithers, Bernard Mark, Atkinson, Victoria and Wachter, Eric Andrew (2019). Phase 1b study of PV-10 and anti-PD-1 in advanced cutaneous melanoma. Annual Meeting of the American Society of Clinical Oncology (ASCO), Chicago, Il, United States, May 31-June 4, 2019. Alexandria, VA, United States: American Society of Clinical Oncology. doi: 10.1200/JCO.2019.37.15_suppl.9559 |
|
2019 Journal Article Sun protection behaviour after diagnosis of high-risk primary melanoma and risk of a subsequent primaryvon Schuckmann, Lena A., Wilson, Louise F., Hughes, Maria Celia B., Beesley, Vanessa L., Janda, Monika, van der Pols, Jolieke C., Smithers, B. Mark, Khosrotehrani, Kiarash and Green, Adele C. (2019). Sun protection behaviour after diagnosis of high-risk primary melanoma and risk of a subsequent primary. Journal of the American Academy of Dermatology, 80 (1), 139-148.e4. doi: 10.1016/j.jaad.2018.06.068 |
|
2019 Conference Publication IRF4 rs12203592*T/T genotype is associated with nodular melanomaRayner, Jenna E., McMeniman, Erin K., Duffy, David L., De'Ambrosis, Brian, Smithers, B Mark, Jagirdar, Kasturee, Lee, Katie J., Soyer, H. Peter and Sturm, Richard A. (2019). IRF4 rs12203592*T/T genotype is associated with nodular melanoma. ASDR Annual Scientific Meeting 2019, Melbourne, VIC, Australia, 16-17 May 2019. |
|
2019 Book Chapter Ablation for patients with Barrett or DysplasiaSmithers, B. Mark and Thomson, Iain (2019). Ablation for patients with Barrett or Dysplasia. Schakelford's Surgery of the Alimentary Tract. (pp. 350-361) edited by Charles J. Yeo, Steven R. DeMeester, David W. McFadden, Jeffrey B. Matthews and Fleshman James W.. Philadelphia, PA, United States: Elsevier. doi: 10.1016/B978-0-323-40232-3.00034-0 |
|
2019 Conference Publication SOX18 activation in primary melanoma tumoursChong, S., Rowe, C., Malt, M., Smithers, M., Green, A. and Khosrotehrani, K. (2019). SOX18 activation in primary melanoma tumours. Australasian College of Dermatologists, 52nd Annual Scientific Meeting, Melbourne, VIC Australia, 18–21 May 2019. Richmond, VIC Australia: Wiley-Blackwell. |
|
2019 Conference Publication Efficacy of immune checkpoint inhibitors (ICIs) for in-transit melanomaTie, Emilia Nan, Lai-Kwon, Julia Elizabeth, Na, Lumine, Rtshiladze, Michael Alexander, Bozzi, James, Read, Tavis, Atkinson, Victoria, Au-Yeung, George, Long, Georgina V., McArthur, Grant A., Sandhu, Shahneen Kaur, Saw, Robyn, Walpole, Euan Thomas, Menzies, Alexander M., Smithers, B. Mark and Gyorki, David E. (2019). Efficacy of immune checkpoint inhibitors (ICIs) for in-transit melanoma. Annual Meeting of the American Society of Clinical Oncology (ASCO), Chicago, IL United States, 31 May - 4 June 2019. Alexandria, VA United States: American Society of Clinical Oncology. |
|
2019 Book Chapter Esophageal UlcersFrankel, Adam J. and Smithers, B. Mark (2019). Esophageal Ulcers. Encyclopedia of Gastroenterology. (pp. 400-403) London, United Kingdom: Elsevier. doi: 10.1016/B978-0-12-801238-3.65935-4 |
|
2019 Journal Article Survival of patients with early invasive melanoma down-staged under the new 8 AJCC editionvon Schuckmann, Lena A., Hughes, Maria Celia B., Lee, Rebecca, Lorigan, Paul, Khosrotehrani, Kiarash, Smithers, B. Mark and Green, Adele C. (2019). Survival of patients with early invasive melanoma down-staged under the new 8 AJCC edition. Journal of the American Academy of Dermatology, 80 (1), 272-274. doi: 10.1016/j.jaad.2018.04.017 |
|
2019 Conference Publication Long-term oncologic outcomes following isolated limb infusion for locoregional metastatic melanoma: an international multi-center analysisMiura, J. T., Kroon, H. M., Beasley, G., Farrow, N. E., Mosca, P. J., Lowe, M., Farley, C., Kim, Y., Naqvi, S., Potdar, A., Daou, H., Sun, J., Mullen, D., Farma, J., Henderson, M., Serpell, J., Delman, K. A., Smithers, M., Coventry, B., Tyler, D. S., Thompson, J. and Zager, J. (2019). Long-term oncologic outcomes following isolated limb infusion for locoregional metastatic melanoma: an international multi-center analysis. 72nd Annual Cancer Symposium of the Society of Surgical Oncology (SSO), San Diego, California, 27-30 March 2019 . New York, NY, United States: Springer. |
|
2019 Conference Publication Clinicopathological factors associated with death from thin (<= 1 mm) melanomaClaeson, M., Baade, P., Brown, S., Soyer, P., Smithers, M., Green, A., Whiteman, D. and Khosrotehrani, K. (2019). Clinicopathological factors associated with death from thin ( |
|
2019 Conference Publication FDG-PET response assessment in patients with locally advanced nodal melanoma undergoing high-dose neo-adjuvant or definitive radiotherapyTrada, Y., Law, P. W., Bernard, A., Foote, M. C., Barbour, A., Lambie, D., Smithers, M., Burmeister, B. and Pinkham, M. B. (2019). FDG-PET response assessment in patients with locally advanced nodal melanoma undergoing high-dose neo-adjuvant or definitive radiotherapy. 61st Annual Meeting of the American Society for Radiation Oncology (ASTRO), Chicago, Illinois, 15-18 September 2019 . Philadelphia, PA, United States: Elsevier. doi: 10.1016/j.ijrobp.2019.06.2489 |
|
2019 Journal Article Pancreaticoduodenectomy in a low-resection volume region: a population-level study examining the impact of hospital-volume on surgical quality and longer-term survivalNarendra, Aaditya, Baade, Peter D., Aitken, Joanne F., Fawcett, Jonathan and Smithers, Bernard Mark (2019). Pancreaticoduodenectomy in a low-resection volume region: a population-level study examining the impact of hospital-volume on surgical quality and longer-term survival. HPB, 22 (9), 1288-1294. doi: 10.1016/j.hpb.2019.11.015 |
|
2018 Journal Article Guidelines for perioperative care in esophagectomy: Enhanced Recovery After Surgery (ERAS®) Society recommendationsLow, Donald E., Allum, William, De Manzoni, Giovanni, Ferri, Lorenzo, Immanuel, Arul, Kuppusamy, Madhan Kumar, Law, Simon, Lindblad, Mats, Maynard, Nick, Neal, Joseph, Pramesh, C. S., Scott, Mike, Mark Smithers, B., Addor, Valérie and Ljungqvist, Olle (2018). Guidelines for perioperative care in esophagectomy: Enhanced Recovery After Surgery (ERAS®) Society recommendations. World Journal of Surgery, 43 (2), 299-330. doi: 10.1007/s00268-018-4786-4 |
|
2018 Conference Publication Progression-free survival and recurrence results for AGITG DOCTOR: Pre-op cisplatin, 5FU & DOCetaxel plus /-radiotherapy after poor early response to cisplatin & 5FU for resectable oesophageal adenocarcinomaBarbour, A. P., Walpole, E. T., Mai, G. T., Barnes, L., Watson, D. I., Ackland, S. P., Wills, V., Martin, J., Burge, M., Karapetis, C. S., Shannon, J., Nott, L. M., Gebski, V., Oostendorp, M., Wilson, K., Thomas, J., Lampe, G., Zalcberg, J. R., Simes, J. and Smithers, M. (2018). Progression-free survival and recurrence results for AGITG DOCTOR: Pre-op cisplatin, 5FU & DOCetaxel plus /-radiotherapy after poor early response to cisplatin & 5FU for resectable oesophageal adenocarcinoma. 43rd ESMO Congress (ESMO), Munich Germany, Oct 19-23, 2018. OXFORD: OXFORD UNIV PRESS. |
|
2018 Journal Article Multicentre factorial randomized clinical trial of perioperative immunonutrition versus standard nutrition for patients undergoing surgical resection of oesophageal cancerMudge, L. A., Watson, D. I., Smithers, B. M., Isenring, E. A., Smith, L., Jamieson, G. G., Australian Immunonutrition Study Group and McFarlane, Catherine (2018). Multicentre factorial randomized clinical trial of perioperative immunonutrition versus standard nutrition for patients undergoing surgical resection of oesophageal cancer. The British Journal of Surgery, 105 (10), 1262-1272. doi: 10.1002/bjs.10923 |
|
2018 Journal Article In response to: immigration is the most likely reason for the generational change in melanoma incidence in Queensland, AustraliaAitken, Joanne F., Youlden, Danny R., Baade, Peter D., Soyer, H. Peter, Green, Adele C. and Smithers, B. Mark (2018). In response to: immigration is the most likely reason for the generational change in melanoma incidence in Queensland, Australia. International Journal of Cancer, 143 (3), 722-723. doi: 10.1002/ijc.31347 |
